To put it simply the Ebioscience signing was a turning point for the company.
The deal will provide a modest upfront payment and an increase in quarterly cashflows to breakeven and beyond.
This was a signing for the longer term holders not the traders as the upfront will be $100 - $200k IMO and the real money will flow from this deal over the coming years.
This deal although important represents about 2% of the reason I am invested here.
ebiosciece deal - a company transformer?, page-3
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 828094 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1102151 | 4 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |